OVOL1 and Alzheimer disease: The dramatic and persistent increase in dermal γδT cells in AD-like SSKO skin led us to investigate whether these cells function downstream of Ovol1 deficiency-induced barrier dysregulation to promote exacerbated inflammation and pathology.